MabPair IO Therapy
Cancer (Immuno-oncology)
Phase 1Active
Key Facts
About Sound Biologics
Sound Biologics is a clinical-stage biotech leveraging its proprietary MabPair and Bispecific platforms to create novel antibody combination therapies. The company's lead immuno-oncology program has reached patients in China, with additional programs advancing in inflammation and neurology. Sound Biologics aims to improve therapeutic efficacy and accessibility by streamlining combination treatments into single, manufacturable drug products.
View full company profileTherapeutic Areas
Other Cancer (Immuno-oncology) Drugs
| Drug | Company | Phase |
|---|---|---|
| Platform Application: CAR-T Enhancement | NTrans Technologies | Pre-clinical |